Selective PGHS-2 inhibitors: A rational approach for treatment of the inflammation

被引:24
作者
Rodrigues, CR
Veloso, MP
Verli, H
Fraga, CAM
Miranda, ALP
Barreiro, EJ
机构
[1] Univ Fed Rio de Janeiro, Lab Avalicao & Sintese Substancias Bioat, Fac Farm, BR-21944970 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Dept Quim Organ, Inst Quim, BR-21944970 Rio De Janeiro, Brazil
关键词
NSAIDs; PGHS-2; inhibitors; 3D-pharmacophore model; molecular dynamics;
D O I
10.2174/0929867024606786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin-H synthase exists in two isoforms, PGHS-1 and PGHS-2. PGHS-I is present and is constitutively expressed in most cells and tissues, whereas PGHS-2 is mainly thought to mediate inflammation. Selective prostaglandin-H synthase-2 (or cyclooxygenase-2) inhibitors have been shown to be potent anti inflammatory agents with fewer side effects than currently marketed nonsteroidal anti inflammatory drugs (NSAIDs). This review addresses the main classes of the selective PGHS-2 inhibitors whose selectivity is documented by supporting PGHS-I and PGHS-2 enzyme data. In addition, we also describe our experience in design, synthesis and pharmacological in vivo evaluation of new 1,2-benzodioxole derivatives as candidate of the selective PGHS-2 inhibitors, with special attention to molecular dynamics simulations of these derivatives attached to the active site of PGHS-2.
引用
收藏
页码:849 / 867
页数:19
相关论文
共 87 条
[41]   Synthesis and biological evaluation of both enantiomers of L-761,000 as inhibitors of cyclooxygenase 1 and 2 [J].
Leblanc, Y ;
Black, WC ;
Chan, CC ;
Charleson, S ;
Delorme, D ;
Denis, D ;
Gauthier, JY ;
Grimm, EL ;
Gordon, R ;
Guay, D ;
Hamel, P ;
Kargman, S ;
Lau, CK ;
Mancini, J ;
Ouellet, M ;
Percival, D ;
Roy, P ;
Skorey, K ;
Tagari, P ;
Vickers, P ;
Wong, E ;
Xu, L ;
Prasti, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) :731-736
[42]   CYCLOOXYGENASE-2 INHIBITORS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITIES OF 5-METHANESULFONAMIDO-1-INDANONE DERIVATIVES [J].
LI, CS ;
BLACK, WC ;
CHAN, CC ;
FORDHUTCHINSON, AW ;
GAUTHIER, JY ;
GORDON, R ;
GUAY, D ;
KARGMAN, S ;
LAU, CK ;
MANCINI, J ;
OUIMET, N ;
ROY, P ;
VICKERS, P ;
WONG, E ;
YOUNG, RN ;
ZAMBONI, R ;
PRASIT, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4897-4905
[43]   Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H-2 synthase cyclooxygenase active site [J].
Loll, PJ ;
Picot, D ;
Ekabo, O ;
Garavito, RM .
BIOCHEMISTRY, 1996, 35 (23) :7330-7340
[44]   ARGININE-120 OF PROSTAGLANDIN G/H SYNTHASE-1 IS REQUIRED FOR THE INHIBITION BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS CONTAINING A CARBOXYLIC-ACID MOIETY [J].
MANCINI, JA ;
RIENDEAU, D ;
FALGUEYRET, JP ;
VICKERS, PJ ;
ONEILL, GP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) :29372-29377
[45]   Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents [J].
Marnett, LJ ;
Kalgutkar, AS .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :482-490
[46]   Cyclooxygenase 2 inhibitors: discovery, selectivity and the future [J].
Marnett, LJ ;
Kalgutkar, AS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (11) :465-469
[47]  
Murray M D, 1997, Prog Drug Res, V49, P155
[48]   Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx™) [J].
Nicoll-Griffith, DA ;
Yergey, JA ;
Trimble, LA ;
Silva, JM ;
Li, C ;
Chauret, N ;
Gauthier, JY ;
Grimm, E ;
Léger, S ;
Roy, P ;
Thérien, M ;
Wang, ZY ;
Prasit, P ;
Zamboni, R ;
Young, RN ;
Brideau, C ;
Chan, CC ;
Mancini, J ;
Riendeau, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (23) :2683-2686
[49]   Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423 [J].
Ochi, T ;
Jobo-Magari, K ;
Yonezawa, A ;
Matsumori, K ;
Fujii, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 365 (2-3) :259-266
[50]   EXPRESSION OF MESSENGER-RNA FOR CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 IN HUMAN TISSUES [J].
ONEILL, GP ;
FORDHUTCHINSON, AW .
FEBS LETTERS, 1993, 330 (02) :156-160